ch.oddb.org
 
Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
Fachinformation zu Imodium® lingual akut®:JNTL Consumer Health II (Switzerland) GmbH
Vollst. FachinformationDDDÄnderungen anzeigenDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info. 
A07DA03 - LoperamideATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A07 - Antidiarrheals, Intestinal Antiinflammatory/Antiinfective Agents
 
A07D - Antipropulsives
 
A07DA - Antipropulsives

This group comprises agents which reduce gastrointestinal motility, e.g. diphenoxylate and loperamide. Loperamide and loperamide oxide are classified at the two separate 5th levels.
A07DA01 - diphenoxylate - includes combinations with atropine.
A07DA02 - opium - includes also combinations with belladonna and/or bismuth subgallate, albumin etc.
A07DA52 - morphine, combinations includes combinations with e.g. aluminum hydroxide, belladonna alkaloids and kaolin used as antipropulsives. Morphine combinations used in the treatment of pain are classified in N02AA51.
Combinations with antiflatulents are classified here.

The DDDs are based on treatment of acute diarrhea.

A07DA03 - Loperamide
StärkeAdm.RouteNote
 O 
2024 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home